United States · FDA National Drug Code directory
SPIRONOLACTONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-557_f8b9eb31-4486-7638-e053-6394a90aee92
- Product NDC
- 76420-557
- Form
- TABLET, FILM COATED
- Composition / generic term
- SPIRONOLACTONE
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19860723
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-557-01) · 76420-557-01
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-557-30) · 76420-557-30
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-557-60) · 76420-557-60
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-557-90) · 76420-557-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →